Skip to content

Effectiveness evaluation of Foeniculum Vulgare preparation on postpartum dyspareunia in primiparous women

Effectiveness evaluation of Foeniculum Vulgare L. (Fennel) preparation on postpartum dyspareunia in primiparous women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160308026971N9
Enrollment
30
Registered
2020-02-15
Start date
2019-01-20
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspareunia. Dyspareunia

Interventions

Intervention 1: Intervention group: from the end of the second week after delivery and the beginning of the third week, the 500 mg capsule of Fennel beans will be taken every 12 hours for one number f

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: The desire to participate in the study Living with spouse It's been two weeks since the childbirth of a newborn baby Mother's age is 18-35 years old Not having postpartum depression Infant feeding with breast milk Not known for chronic disease No rupture of grade 3 and 4 at delivery No alcohol, cigarettes and drugs addiction No history of mental illness

Exclusion criteria

Exclusion criteria: Breastfeeding less than 3 times a day (for one day and more) Away from the husband Extreme marital conflicts The occurrence of a horrible event (deaths of loved ones in the past six months and accidents, etc.) Severe bleeding after delivery

Design outcomes

Primary

MeasureTime frame
Severity of postpartum dyspareunia. Timepoint: 4 and 8 weeks after taking Foeniculum Vulgare. Method of measurement: The Marinof Dyspareunia Scale is a 4-part and specific dispatcher questionnaire which is available to women and chooses one option depending on the severity of the problem.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzeyeh Loripoor

Rafsanjan University of Medical Sciences

marzeyehloripoor@yahoo.com+98 34 3428 0035

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026